Cytochrome P450 2B6 Inhibitors [MoA] - N0000182139
Pharmacologic Class Information
Pharmacologic Code | N0000182139 |
Pharmacologic Name | Cytochrome P450 2B6 Inhibitors |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Cytochrome P450 2B6 Inhibitors
The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Cytochrome P450 2B6 Inhibitors [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0024-4512 | Fexinidazole | Non-Proprietary Name: Fexinidazole | Tablet | Oral | Sanofi-aventis U.s. Llc | ACTIVE | |
0069-8140 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0069-8141 | Xalkori | Non-Proprietary Name: Crizotinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
0078-0937 | Egaten | Non-Proprietary Name: Triclabendazole | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE | |
17772-131 | Qelbree | Non-Proprietary Name: Viloxazine Hydrochloride | Capsule, Extended Release | Oral | Supernus Pharmaceuticals, Inc | ACTIVE | |
17772-132 | Qelbree | Non-Proprietary Name: Viloxazine Hydrochloride | Capsule, Extended Release | Oral | Supernus Pharmaceuticals, Inc | ACTIVE | |
17772-133 | Qelbree | Non-Proprietary Name: Viloxazine Hydrochloride | Capsule, Extended Release | Oral | Supernus Pharmaceuticals, Inc | ACTIVE | |
70127-100 | Epidiolex | Non-Proprietary Name: Cannabidiol | Solution | Oral | Greenwich Biosciences, Llc | ACTIVE | |
72065-003 | Recorlev | Non-Proprietary Name: Levoketoconazole | Tablet | Oral | Xeris Pharmaceuticals, Inc. | ACTIVE |